Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 4,469 GBp
Change Today +95.00 / 2.17%
Volume 2.8M
AZN On Other Exchanges
Symbol
Exchange
New York
Xetra
London
Stockholm
OTC US
Mexico
Berlin
As of 11:35 AM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Karen Gotting-Smith Ph.D.

Former Vice President of Development - Business Performance and Continuous Improvement, AstraZeneca PLC
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

----

Background*

Ms. Karen Gotting-Smith, Ph.D., served as a Vice President of Development for Business Performance and Continuous Improvement at AstraZeneca plc and served as Vice President of Clinical Development at AstraZeneca Pharmaceuticals LP. Ms. Gotting-Smith was leader in AstraZeneca Clinical Development in September 2005. Ms. Gotting-Smith served as Global Product Director for CRESTOR® (rosuvastatin calcium). She led the cross-functional global product team through regulatory ...

Read Full Background

Corporate Headquarters*

2 Kingdom Street
London, Greater London W2 6BD

United Kingdom

Phone: 44 20 7604 8000
Fax: 44 20 7604 8151

Board Members Memberships*

Former Director

Education*

PhD
University of Cardiff
BS
University of Cardiff

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AZN:LN 4,468.50 GBp +95.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Inc.
$1.4M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.4M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.9M
Kurt W. Bock Chairman of The Board of Executive Directors and Chief Executive Officer
BASF SE
€3.9M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTRAZENECA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.